Search Results - "R Cappelletti, M"

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer by Allevi, G, Strina, C, Andreis, D, Zanoni, V, Bazzola, L, Bonardi, S, Foroni, C, Milani, M, Cappelletti, M R, Gussago, F, Aguggini, S, Giardini, R, Martinotti, M, Fox, S B, Harris, A L, Bottini, A, Berruti, A, Generali, D

“…Background: The objective of this study was to determine the optimal scheduling of 2.5 mg daily letrozole in neoadjuvant breast cancer patients to obtain…”
Get full text

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy by Koukourakis, M I, Giatromanolaki, A, Bottini, A, Cappelletti, M R, Zanotti, L, Allevi, G, Strina, C, Ardine, M, Milani, M, Brugnoli, G, Martinotti, M, Ferrero, G, Bertoni, R, Ferrozzi, F, Harris, A L, Generali, D

“…Background: Although Trastuzumab has improved survival of HER2+ breast cancer patients, resistance to the agent pre-exists or develops through the course of…”
Get full text

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer by Bazzola, L, Foroni, C, Andreis, D, Zanoni, V, R Cappelletti, M, Allevi, G, Aguggini, S, Strina, C, Milani, M, Venturini, S, Ferrozzi, F, Giardini, R, Bertoni, R, Turley, H, Gatter, K, Petronini, P G, Fox, S B, Harris, A L, Martinotti, M, Berruti, A, Bottini, A, Reynolds, A R, Generali, D

“…Purpose: To assess whether the combination of letrozole, metronomic cyclophosphamide and sorafenib (LCS) is well tolerated and shows activity in primary breast…”
Get full text

Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: A literature-based meta-analysis of randomized trials by Corona, S.P., Roviello, G., Strina, C., Milani, M., Madaro, S., Zanoni, D., Allevi, G., Aguggini, S., Cappelletti, M.R., Francaviglia, M., Azzini, C., Cocconi, A., Sirico, M., Bortul, M., Zanconati, F., Giudici, F., Rosellini, P., Meani, F., Pagani, O., Generali, D.

“…Endocrine treatment with Tamoxifen and aromatase inhibitors (AIs) is a staple in the management of hormone receptor positive breast cancer (HR + BC). It has…”
Get full text

Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1  and Relation to Clinical Response by Generali, D., Berruti, A., Cappelletti, M. R., Zanotti, L., Brugnoli, G., Forti, M., Bedussi, F., Vailati, M. E., Milani, M., Strina, C., Ardine, M., Aguggini, S., Allevi, G., Ferrero, G., Bertoni, R., Bottini, A., Harris, A. L., Fox, S. B.

Get full text

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) by Amoroso, Vito, Generali, Daniele, Buchholz, Thomas, Cristofanilli, Massimo, Pedersini, Rebecca, Curigliano, Giuseppe, Daidone, Maria Grazia, Di Cosimo, Serena, Dowsett, Mitchell, Fox, Stephen, Harris, Adrian L., Makris, Andreas, Vassalli, Lucia, Ravelli, Andrea, Cappelletti, Maria Rosa, Hatzis, Christos, Hudis, Clifford A., Pedrazzoli, Paolo, Sapino, Anna, Semiglazov, Vladimir, Von Minckwitz, Gunter, Simoncini, Edda L., Jacobs, Michael A., Barry, Peter, Kühn, Thorsten, Darby, Sarah, Hermelink, Kerstin, Symmans, Fraser, Gennari, Alessandra, Schiavon, Gaia, Dogliotti, Luigi, Berruti, Alfredo, Bottini, Alberto

“…Expert consensus-based recommendations regarding key issues in the use of primary (or neoadjuvant) systemic treatment (PST) in patients with early breast…”
Get full text

RNA Disruption and Drug Response in Breast Cancer Primary Systemic Therapy by Pritzker, Kenneth, Pritzker, Laura, Generali, Daniele, Bottini, Alberto, Cappelletti, Maria Rosa, Guo, Baoqing, Parissenti, Amadeo, Trudeau, Maureen

“…Background: As there is now evidence that switching clinical nonresponders early in primary systemic therapy to alternate treatment regimens can enhance…”
Get full text

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer? by Generali, Daniele, Ardine, Mara, Strina, Carla, Milani, Manuela, Cappelletti, Maria Rosa, Zanotti, Laura, Forti, Michela, Bedussi, Francesca, Martinotti, Mario, Amoroso, Vito, Sigala, Sandra, Simoncini, Edda, Berruti, Alfredo, Bottini, Alberto

“…Breast cancer represents a heterogeneous group of diseases with varied biological features, behavior, and response to therapy; thus, management of breast…”
Get full text

P4-16-03: Proof of the Anti-Tumour Effect of Zoledronic Acid (ZA) in Naive Bone-Only Metastatic and Locally Advanced Breast Cancer: Results from the Biological Window Therapy by Foroni, C, Andreis, D, Maldotti, M, Cappelletti, MR, Generali, DG

“…Abstract Background: Pre-clinical studies have demonstrated an anti-tumour activity of ZA in several cancers. However, the clinical evidence of the ZA…”
Get full text

Abstract S3-01: IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy by Bidard, F-C, Michiels, S, Mueller, V, Riethdorf, S, Esserman, LJ, Lucci, A, Naume, B, Horiguchi, J, Gisbert-Criado, R, Sleijfer, S, Toi, M, Garcia-Saenz, JA, Hartkopf, A, Generali, D, Rothe, F, Smerage, J, Muinelo, L, Stebbing, J, Viens, P, Magbanua, M, Hall, CS, Engebråtenm, O, Takata, D, Vidal-Martínez, J, Onstenk, W, Fujisawa, N, Diaz-Rubio, E, Taran, F-A, Cappelletti, MR, Ignatiadis, M, Name, N, Proudhon, C, Wolf, D, Bowman Bauldry, J, Borgen, E, Nagaoka, R, Carañana, V, Kraan, J, Maestro, M, Brucker, SY, Weber, K, Reyal, F, Amara, D, Gopalkrishna Karhade, M, Ruud Mathiesen, R, Tokiniwa, H, Llombart-Cussac, A, D'Hollander, K, Cottu, P, Park, JW, Loibl, S, Pierga, J-Y, Pantel, K

“…Abstract Background We performed an international meta-analysis of individual patient data to assess the clinical validity of circulating tumor cell (CTC)…”
Get full text

Abstract PD07-03: INCREASED PATHOLOGIC COMPLETE RESPONSE RATE AFTER A LONG TERM NEOADJUVANT LETROZOLE TREATMENT IN POSTMENOPAUSAL ESTROGEN AND/OR PROGESTERONE RECEPTOR-POSITIVE BREAST CANCER by Allevi, G, Strina, C, Andreis, D, Zanoni, V, Bazzola, L, Bonardi, S, Foroni, C, Milani, M, Cappelletti, MR, Generali, D, Berruti, A, Bottini, A

“…Abstract Background: Neoadjuvant endocrine therapy has been increasingly employed in clinical practice to improve surgical options for postmenopausal women…”
Get full text

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma by Bonetta, Alberto, Roviello, Giandomenico, Generali, Daniele, Zanotti, Laura, Cappelletti, Maria Rosa, Pacifico, Chiara, Di Pierro, Francesco

“…Worldwide, bacterial resistance to antibiotic therapy is a major concern for the medical community. Antibiotic resistance mainly affects Gram-negative bacteria…”
Get full text